title: A robotic BG1Luc reporter assay to detect estrogen receptor agonists.
abstract: Endocrine disrupting chemicals with estrogenic activity (EA) have been associated with various adverse health effects. US agencies (ICCVAM/NICEATM) tasked to assess in vitro transcription activation assays to detect estrogenic receptor (ER) agonists for EA have recently validated a BG1Luc assay in manual format, but prefer robotic formats. We have developed a robotic BG1Luc EA assay to detect EA that demonstrated 100% concordance with ICCVAM meta-analyses and ICCVAM BG1Luc results in manual format for 27 ICCVAM test substances, i.e. no false negatives or false positives. This robotic assay also consistently assessed other, more problematic ICCVAM test substances such as clomiphene citrate, L-thyroxin, and tamoxifen. Agonist responses using this robotic BG1Luc assay were consistently inhibited by the ER antagonist ICI 182,780, confirming that agonist responses were due to binding to ERs rather than to a non-specific agonist response. This robotic assay also detected EA in complex mixtures of substances such as extracts of personal care products, plastic resins or plastic consumer products. This robotic BG1Luc assay had at least as high accuracy and greater sensitivity and repeatability when compared to its manual version or to the other ICCVAM/OECD validated assays for EA (manual BG1Luc and CERI).
authors.affiliation: CertiChem, Inc., Austin, TX, USA.
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Stoner
authors.affiliation: CertiChem, Inc., Austin, TX, USA.
authors.forename: Chun Z
authors.initials: CZ
authors.lastname: Yang
authors.affiliation: CertiChem, Inc., Austin, TX, USA; Neuroscience Department, University of Texas, Austin, TX, USA. Electronic address: gbittner@certichem.com.
authors.forename: George D
authors.initials: GD
authors.lastname: Bittner
mesh_terms: D001681:Biological Assay; D002460:Cell Line; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology; D065171:Estrogen Receptor Antagonists / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D000077267:Fulvestrant; D017930:Genes, Reporter; D006801:Humans; D008156:Luciferases / Q000235:genetics / Q000378:metabolism; D015203:Reproducibility of Results; D012371:Robotics; D012680:Sensitivity and Specificity
chemical_list: D065171:Estrogen Receptor Antagonists; D004967:Estrogens; D000077267:Fulvestrant; D004958:Estradiol; D008156:Luciferases
keywords: BG1Luc; Bisphenol A; Endocrine disruptor; Estrogen; Estrogenic activity; Tritan™
references.citation: Proc Soc Exp Biol Med. 1987 Sep;185(4):478-83
references.pmid: 3615411
references.citation: Cien Saude Colet. 2012 Feb;17(2):407-34
references.pmid: 22267036
references.citation: Toxicology. 2005 Sep 1;212(2-3):244-52, author reply 253-4
references.pmid: 15975703
references.citation: Philos Trans R Soc Lond B Biol Sci. 2009 Jul 27;364(1526):1973-6
references.pmid: 19528049
references.citation: Environ Health Perspect. 2011 Jul;119(7):989-96
references.pmid: 21367689
references.citation: Philos Trans R Soc Lond B Biol Sci. 2009 Jul 27;364(1526):2079-96
references.pmid: 19528057
references.citation: Toxicol Sci. 2009 Jan;107(1):122-34
references.pmid: 18996888
references.citation: Acta Paediatr. 2012 Aug;101(8):811-8
references.pmid: 22458970
references.citation: Neurotoxicology. 2011 Jan;32(1):38-49
references.pmid: 20696184
references.citation: Cancer Res. 1991 Aug 1;51(15):3867-73
references.pmid: 1855205
references.citation: Mol Pharmacol. 1998 Jul;54(1):105-12
references.pmid: 9658195
references.citation: Mol Cell Endocrinol. 2009 May 25;304(1-2):90-6
references.pmid: 19433253
references.citation: Breast Cancer Res Treat. 1993;26(2):131-7
references.pmid: 8219250
references.citation: In Vitr Mol Toxicol. 2000 Spring;13(1):67-82
references.pmid: 10900408
references.citation: Toxicol Sci. 2014 Feb;137(2):335-49
references.pmid: 24213142
references.citation: Pharmacol Ther. 1981;15(3):467-519
references.pmid: 7048350
references.citation: Chemosphere. 2004 Dec;57(11):1649-55
references.pmid: 15519410
references.citation: Environ Health Perspect. 2003 Jul;111(9):1180-7
references.pmid: 12842771
references.citation: Environ Health Perspect. 2005 Apr;113(4):391-5
references.pmid: 15811827
references.citation: Mol Carcinog. 2013 Sep;52(9):715-25
references.pmid: 22549810
references.citation: Environ Health Perspect. 2005 Aug;113(8):1056-61
references.pmid: 16079079